Utah Retirement Systems’s Haemonetics HAE Stock Holding History

Utah Retirement Systems’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,985	Closed	-$465K	–	994
2021 Q2	$465K	Sell	6,985 -2,600	-27%	-$184K	0.01%	850
2021 Q1	$1.06M	Sell	9,585 -400	-4%	-$49.5K	0.01%	764
2020 Q4	$1.19M	Buy	9,985 +500	+5%	+$53.8K	0.02%	706
2020 Q3	$827K	Hold	9,485	–	–	0.01%	732
2020 Q2	$849K	Buy	9,485 +1,900	+25%	+$192K	0.02%	697
2020 Q1	$756K	Hold	7,585	–	–	0.02%	675
2019 Q4	$872K	Buy	7,585 +100	+1%	+$12.1K	0.02%	772
2019 Q3	$944K	Hold	7,485	–	–	0.02%	734
2019 Q2	$901K	Buy	7,485 +26	+0.3%	+$2.56K	0.02%	761
2019 Q1	$653K	Buy	+7,459	New	+$678K	0.01%	858

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Utah Retirement Systems's HAE Position: Q3 2021 in Review

Utah Retirement Systems sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 6,985 shares — an estimated $465K sold.

Utah Retirement Systems first reported a position in HAE in Q1 2019 and held it in 10 quarters. The position peaked at $1.19M in Q4 2020. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

Utah Retirement Systems reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
Utah Retirement Systems sold 6,985 Haemonetics shares in Q3 2021, an estimated $465K.
Utah Retirement Systems first reported a position in Haemonetics in Q1 2019 and held it in 10 quarters.
Utah Retirement Systems's Haemonetics position peaked at $1.19M in Q4 2020.
245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on Utah Retirement Systems's 13F filing for Q3 2021, filed 16 Nov 2021.